Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013 (2013), Article ID 731071, 13 pages
http://dx.doi.org/10.1155/2013/731071
Research Article

Relationship between EGF, TGFA, and EGFR Gene Polymorphisms and Traditional Chinese Medicine ZHENG in Gastric Cancer

1Discipline of Chinese and Western Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China
2College of Basic Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China
3Department of Clinical Laboratory, First Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210029, China
4Department of TCM Oncology, First Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210029, China

Received 17 July 2013; Revised 23 October 2013; Accepted 20 November 2013

Academic Editor: Shi-bing Su

Copyright © 2013 Junfeng Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. Zagouri, C. A. Papadimitriou, M.-A. Dimopoulos, and D. Pectasides, “Molecularly targeted therapies in unresectable-metastatic gastric cancer. A systematic review,” Cancer Treatment Reviews, vol. 37, no. 8, pp. 599–610, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. C. J. Li, P. K. Wei, J. Shi, L. Liu, and D. W. Ju, “Ideas and methods in treating gastric cancer by Traditional Chinese Medicine “Tan” (phlegm),” Zhong Guo Zhong Yi Yao Xin Xi Za Zhi, vol. 14, no. 8, pp. 84–86, 2007 (Chinese). View at Google Scholar
  3. X. P. Liu, P. Q. Li, and W. Zhang, “Ideas and methods in preventing and treating peritoneal metastasis of gastric cancer by Traditional Chinese Medicine,” Zhong Yi Za Zhi, vol. 53, no. 4, pp. 288–290, 2012 (Chinese). View at Google Scholar
  4. X. Liu and B. J. Hua, “Effect of traditional Chinese medicine on quality of life and survival period in patients with progressive gastric cancer,” Zhong Guo Zhong Xi Yi Jie He Za Zhi, vol. 28, no. 2, pp. 592–594, 2008 (Chinese). View at Google Scholar · View at Scopus
  5. C. J. Li, P. K. Wei, and B. L. Yu, “Study on the mechanism of Xiaotan Sanjie Recipe for inhibiting proliferation of gastric cancer cells,” Journal of Traditional Chinese Medicine, vol. 30, no. 4, pp. 249–253, 2010. View at Google Scholar · View at Scopus
  6. H. Bao, J. Gao, T. Huang, Z. M. Zhou, B. Zhang, and Y.-F. Xia, “Relationship between traditional Chinese medicine syndrome differentiation and imaging characterization to the radiosensitivity of nasopharyngeal carcinoma,” Chinese Journal of Cancer, vol. 29, no. 11, pp. 937–945, 2010. View at Google Scholar · View at Scopus
  7. A. G. Zhou, J. R. Dong, S. Hong, G. Kui, X. Y. Huang, and X. M. Mao, “Advanced research on the tongue image of the patients with malignant tumors,” Zhe Jiang Zhong Yi Za Zhi, vol. 41, no. 12, pp. 726–728, 2006 (Chinese). View at Google Scholar
  8. L. Y. Chen and G. Z. Lu, “Analysis of tongue images in 114 patients with gastric cancer,” Zhong Yi Za Zhi, vol. 52, no. 22, pp. 1935–1938, 2011 (Chinese). View at Google Scholar
  9. T. Chen, K. Q. Li, M. H. Chen, and R. Liang, “Analysis of tongue diagnosis in 4400 modern well-known doctors' cases of China,” Liao Nin Zhong Yi Za Zhi, vol. 34, no. 9, pp. 1217–1220, 2007 (Chinese). View at Google Scholar
  10. D.-Z. Sun, L. Liu, J.-P. Jiao, P.-K. Wei, L.-D. Jiang, and L. Xu, “Syndrome characteristics of traditional Chinese medicine: summary of a clinical survey in 767 patients with gastric cancer,” Zhong Xi Yi Jie He Xue Bao, vol. 8, no. 4, pp. 332–340, 2010 (Chinese). View at Publisher · View at Google Scholar · View at Scopus
  11. Z. Zhan, J. F. Hao, H. Wang, and Y. H. Ma, “Relationship between tongue coating and saliva h-EGF content of tumor patients,” Nan Jing Zhong Yi Yao Da Xu Xue Bao, vol. 15, no. 6, pp. 350–351, 1999 (Chinese). View at Google Scholar
  12. J. Zhang, Y. Fan, J. Hao, S. J. Tong, D. Q. Xu, and Z. Zhan, “Differentially expressed genes in common tongue coatings of cancer patients on cDNA microarrays,” Journal of Chinese Clinical Medicine, vol. 3, no. 6, pp. 301–311, 2008. View at Google Scholar
  13. A. J. Wilson and P. R. Gibson, “Role of epidermal growth factor receptor in basal and stimulated colonic epithelial cell migration in vitro,” Experimental Cell Research, vol. 250, no. 1, pp. 187–196, 1999. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Liu, X. R. Chang, J. Yan et al., “Effects of moxibustion on gastric mucosal EGF and TGF-alpha contents and epidermal growth factor receptor expression in rats with gastric mucosal lesion,” Zhen Ci Yan Jiu, vol. 36, no. 6, pp. 403–408, 2011. View at Google Scholar · View at Scopus
  15. K. Y. Liu, Y. Zhu, and X. Z. Huang, “Effect of Pongamia pinnata root flavonoids on the quality of ulcer healing and expression of EGF and TGF-alpha in the rat model of gastric ulcer induced by acetic acid,” Zhong Guo Ying Yong Sheng Li Xue Za Zhi, vol. 28, no. 5, pp. 435–438, 2012 (Chinese). View at Google Scholar
  16. F. Yan, H. Cao, R. Chaturvedi et al., “Epidermal growth factor receptor activation protects gastric epithelial cells from helicobacter pylori-induced apoptosis,” Gastroenterology, vol. 136, no. 4, pp. 1297–1307, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. E. Mammano, C. Belluco, M. Sciro et al., “Epidermal growth factor receptor (EGFR): mutational and protein expression analysis in gastric cancer,” Anticancer Research, vol. 26, no. 5 A, pp. 3547–3550, 2006. View at Google Scholar · View at Scopus
  18. M. Terashima, K. Kitada, A. Ochiai et al., “Impact of expression of human epidermal growth factor receptors EGFR and ERBB2 on survival in stage II/III gastric cancer,” Clinical Cancer Research, vol. 18, no. 21, pp. 5992–6000, 2012. View at Google Scholar
  19. L. David, R. Seruca, J. M. Nesland et al., “c-erbB-2 expression in primary gastric carcinomas and their metastases,” Modern Pathology, vol. 5, no. 4, pp. 384–390, 1992. View at Google Scholar · View at Scopus
  20. I. R. Ellis, A. M. Schor, and S. L. Schor, “EGF AND TGF-α motogenic activities are mediated by the EGF receptor via distinct matrix-dependent mechanisms,” Experimental Cell Research, vol. 313, no. 4, pp. 732–741, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Baulcombe, “DNA events: an RNA microcosm,” Science, vol. 297, no. 5589, pp. 2002–2003, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Kwan, D. Benovoy, C. Dias et al., “Genome-wide analysis of transcript isoform variation in humans,” Nature Genetics, vol. 40, no. 2, pp. 225–231, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. D. Compare, A. Rocco, and G. Nardone, “Risk factors in gastric cancer,” European Review for Medical and Pharmacological Sciences, vol. 14, no. 4, pp. 302–308, 2010. View at Google Scholar · View at Scopus
  24. W. Masiak, A. Szponar, G. Chodorowska, A. Dąbrowski, T. Pedowski, and G. Wallner, “Evaluation of endostatin and EGF serum levels in patients with gastric cancer,” Polish Journal of Surgery, vol. 83, no. 1, pp. 42–47, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. M. F. Fanelli, L. T. Chinen, M. D. Begnami et al., “The influence of transforming growth factor-alpha, cyclooxygenase-2, matrix metalloproteinase (MMP)-7, MMP-9 and CXCR4 proteins involved in epithelial-mesenchymal transition on overall survival of patients with gastric cancer,” Histopathology, vol. 61, no. 2, pp. 153–161, 2012. View at Google Scholar
  26. A. Yamada, N. Saito, S. Kameoka, and M. Kobayashi, “Clinical significance of Epidermal Growth Factor (EGF) expression in gastric cancer,” Hepato-Gastroenterology, vol. 54, no. 76, pp. 1049–1052, 2007. View at Google Scholar · View at Scopus
  27. G. Yang, L. Rao, L. Tian, and X. Cai, “An association between EGF and EGFR gene polymorphisms with gastric cancer in a Chinese Han population,” Hepatogastroenterology, vol. 59, no. 120, pp. 2668–2671, 2012. View at Google Scholar
  28. W. Q. Li, N. Hu, Z. Wang et al., “Genetic variants in epidermal growth factor receptor pathway genes and risk of esophageal squamous cell carcinoma and gastric cancer in a Chinese population,” PLOS ONE, vol. 8, no. 7, pp. 1–7, 2013. View at Google Scholar
  29. Z. Zhan, Y. Chen, J. Wu et al., “Functional epidermal growth factor gene polymorphisms and risk of gastric cancer,” Oncology Letters, vol. 5, no. 2, pp. 631–636, 2013. View at Google Scholar
  30. S. W. Han, D. Y. Oh, S. A. Im et al., “Epidermal growth factor receptor intron 1 CA dinucleotide repeat polymorphism and survival of advanced gastric cancer patients treated with cetuximab plus modified FOLFOX6,” Cancer Science, vol. 101, no. 3, pp. 793–799, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Goto, T. Ando, H. Goto, and N. Hamajima, “No association between EGF gene polymorphism and gastric cancer,” Cancer Epidemiology Biomarkers and Prevention, vol. 14, no. 10, pp. 2454–2456, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. M. A. Kim, H. S. Lee, H. E. Lee, Y. K. Jeon, H. K. Yang, and W. H. Kim, “EGFR in gastric carcinomas: prognostic significance of protein overexpression and high gene copy number,” Histopathology, vol. 52, no. 6, pp. 738–746, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. Z. Chen and P. Wang, “Clinical distribution and molecular basis of traditional Chinese medicine ZHENG in cancer,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 783923, 8 pages, 2012. View at Publisher · View at Google Scholar
  34. A. Lu, A. Bensoussan, J. Liu, Z. Bian, and W. C. Cho, “TCM zheng classification and clinical trials,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 723659, 3 pages, 2013. View at Publisher · View at Google Scholar
  35. Y. P. Yang, J. Wu, S. J. Tong et al., “Syndrome description of gastric cancer-in terms of TCM syndrome differentiation,” Shi Zhen Guo Yi Guo Yao, vol. 23, no. 10, pp. 2565–2567, 2012 (Chinese). View at Google Scholar
  36. J. Zhang, Z. Zhan, J. Wu et al., “Association among polymorphisms in EGFR gene exons, lifestyle and risk of gastric cancer with gender differences in Chinese Han subjects,” PLOS ONE, vol. 8, no. 3, pp. 1–12, 2013. View at Google Scholar
  37. H. C. Erichsen and S. J. Chanock, “SNPs in cancer research and treatment,” British Journal of Cancer, vol. 90, no. 4, pp. 747–751, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. B. Sobrino, M. Brión, and A. Carracedo, “SNPs in forensic genetics: a review on SNP typing methodologies,” Forensic Science International, vol. 154, no. 2-3, pp. 181–194, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. J. S. You, S. Y. Hu, and H. G. Zhang, “Study on emotion measurement of liver syndromes in TCM and its correlative study on polymorphism of serotonin (5HT) transporter gene,” Zhong Guo Yi Yao Xue Bao, vol. 19, no. 11, pp. 669–671, 2004 (Chinese). View at Google Scholar
  40. Y. F. Wu, Y. C. Zhou, and X.-S. Zhang, “Association between traditional Chinese medicine syndrome of coronary atherosclerotic heart disease and polymorphism of R219K of ABCAI gene in Chinese Han male patients,” Chinese Journal of Clinical Rehabilitation, vol. 10, no. 7, pp. 7–9, 2006. View at Google Scholar · View at Scopus
  41. W. J. Ding, Y. Z. Zeng, W. H. Li et al., “Identification of linkage disequilibrium SNPs from a Kidney-yang deficiency syndrome pedigree,” American Journal of Chinese Medicine, vol. 37, no. 3, pp. 427–438, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. Y. B. Liu, W. Zhang, S. B. Su et al., “Association between liver cirrhosis of hepatitis B cases with Ganqi depression pattern and 5HTTLPRVNTRs, TPH A218C, GNB3 C825T polymorphism,” Zhong Xi Yi Jie He Gan Bing Za Zhi, vol. 20, no. 5, pp. 267–271, 2010 (Chinese). View at Google Scholar
  43. Q. S. Lu, Y. Lei, and K. J. Chen, “Relationship of the A1166C polymorphism of ATI R gene with TCM syndrome and efficacy of Chinese hypotensor in patients with essential hypertension,” Zhongguo Zhong Xi Yi Jie He Za Zhi, vol. 25, no. 8, pp. 682–686, 2005. View at Google Scholar · View at Scopus
  44. Z. L. Jiang, W. Zhang, H. Zhang, Y.-B. Liu, and S. B. Su, “Relationship between TNF-α, TGF-β1 and IL-10 genetic polymorphisms and post-hepatitis B cirrhosis,” World Chinese Journal of Digestology, vol. 17, no. 31, pp. 3263–3268, 2009. View at Google Scholar · View at Scopus
  45. Z.-L. Jiang, W. Zhang, H. Zhang, Y.-B. Liu, Q. Y. Li, and S.-B. Su, “Relationship between gene polymorphisms of interleukin-10 and syndrome types of traditional Chinese medicine in posthepatitis B cirrhosis,” Journal of Chinese Integrative Medicine, vol. 7, no. 11, pp. 1052–1056, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. Q. Y. Li, Z. Z. Guo, J. Liang et al., “Interleukin-10 genotype correlated to deficiency syndrome in hepatitis B cirrhosis,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 298925, 6 pages, 2012. View at Publisher · View at Google Scholar
  47. H. Huang, Y. Bu, and G. H. Zhou, “Single-tube-genotyping of gastric cancer related SNPs by directly using whole blood and paper-dried blood as starting materials,” World Journal of Gastroenterology, vol. 12, no. 24, pp. 3814–3820, 2006. View at Google Scholar · View at Scopus
  48. Z. Liu, L. Liu, M. Li et al., “Epidermal growth factor receptor mutation in gastric cancer,” Pathology, vol. 43, no. 3, pp. 234–238, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. C. Moutinho, A. R. Mateus, F. Milanezi, F. Carneiro, R. Seruca, and G. Suriano, “Epidermal growth factor receptor structural alterations in gastric cancer,” BMC Cancer, vol. 8, article 10, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. Y. Zhu, Q. He, J. Wang, and H. F. Pan, “The association between GSTM1 polymorphism and gastric cancer risk: a meta-analysis,” Molecular Biology Reports, vol. 39, no. 1, pp. 685–691, 2012. View at Publisher · View at Google Scholar · View at Scopus
  51. K. X. Zhu, Y. M. Li, X. Li, W. C. Zhou, Y. Shan, and T. Liu, “Study on the association of p53 codon 72 polymorphisms with risk of gastric cancer in high incidence Hexi area of Gansu Province in China,” Molecular Biology Reports, vol. 39, no. 1, pp. 723–728, 2012. View at Publisher · View at Google Scholar · View at Scopus
  52. Y. Cui, H. Xue, B. Lin, P. Ni, and J. Y. Fang, “A meta-analysis of CDH1 C-160A genetic polymorphism and gastric cancer risk,” DNA and Cell Biology, vol. 30, no. 11, pp. 937–945, 2011. View at Publisher · View at Google Scholar · View at Scopus
  53. X. Zhang, R. Zhong, Z. Zhang et al., “Interaction of Cyclooxygenase-2 promoter polymorphisms with Helicobacter pylori infection and risk of gastric cancer,” Molecular Carcinogenesis, vol. 50, no. 11, pp. 876–883, 2011. View at Publisher · View at Google Scholar · View at Scopus
  54. J. Zhang, Z. Zhan, J. Wu et al., “Association among lifestyle, clinical examination, polymorphisms in CDH1 gene and Traditional Chinese Medicine syndrome differentiation of gastric cancer,” Journal of Traditional Chinese Medicine, vol. 33, no. 5, pp. 572–579, 2013. View at Google Scholar
  55. A. P. Araújo, B. M. Costa, A. L. Pinto-Correia et al., “Association between EGF +61A/G polymorphism and gastric cancer in caucasians,” World Journal of Gastroenterology, vol. 17, no. 4, pp. 488–492, 2011. View at Publisher · View at Google Scholar · View at Scopus
  56. J. Zhu, X. Meng, F. Yan et al., “A functional epidermal growth factor (EGF) polymorphism, EGF serum levels and renal cell carcinoma risk in a Chinese population,” Journal of Human Genetics, vol. 55, no. 4, pp. 236–240, 2010. View at Publisher · View at Google Scholar · View at Scopus
  57. K. Chen, Y. Wei, H. Yang, and B. Li, “Epidermal growth factor +61 G/A polymorphism and the risk of hepatocellular carcinoma in a Chinese population,” Genetic Testing and Molecular Biomarkers, vol. 15, no. 4, pp. 251–255, 2011. View at Publisher · View at Google Scholar · View at Scopus
  58. K. L. Amend, J. T. Elder, L. P. Tomsho et al., “EGF gene polymorphism and the risk of incident primary melanoma,” Cancer Research, vol. 64, no. 8, pp. 2668–2672, 2004. View at Publisher · View at Google Scholar · View at Scopus
  59. Y. Hamai, S. Matsumura, K. Matsusaki et al., “A single nucleotide polymorphism in the 5′ untranslated region of the EGT gene is associated with occurrence and malignant progression of gastric cancer,” Pathobiology, vol. 72, no. 3, pp. 133–138, 2005. View at Publisher · View at Google Scholar · View at Scopus
  60. W. J. Liang, Y. J. Ma, X. Yan, W. D. Zhang, and R.-C. Luo, “Expression of transforming growth factor α and Cyclin E and their correlation in chronic gastric lesion tissues from patients with different TCM types,” World Chinese Journal of Digestology, vol. 16, no. 12, pp. 1355–1358, 2008. View at Google Scholar · View at Scopus
  61. J. B. Li, X. P. Dai, R. X. Jiang, C. Y. Yu, Y. Li, and W. N. Zhang, “Experimental and clinical study on Jianwei Yuyang Granule in treating relapse of peptic ulcer,” Zhong Guo Zhong Xi Yi Jie He Xiao Hua Za Zhi, vol. 12, no. 1, pp. 30–33, 2004 (Chinese). View at Google Scholar
  62. L.-H. Sun, Q. Li, and S. Q. Wang, “Relationship of TCM syndrome type of gastric mucosal epithelial growth factor, vascular endothelial growth factor and proliferative cell nuclear antigen in patients with chronic atrophic gastritis,” Zhong Guo Zhong Xi Yi Jie He Za Zhi, vol. 28, no. 3, pp. 225–228, 2008 (Chinese). View at Google Scholar · View at Scopus
  63. L. Tao and J. K. Yang, “Univariate analysis of syndrome differentiation in traditional Chinese medicine and clinical correlative factors in gastric cancer,” Zhong Xi Yi Jie He Xue Bao, vol. 5, no. 4, pp. 398–402, 2007 (Chinese). View at Google Scholar · View at Scopus
  64. W. Yao, H. Yang, and G. Ding, “Mechanisms of Qi-blood circulation and Qi deficiency syndrome in view of blood and interstitial fluid circulation,” Journal of Traditional Chinese Medicine, vol. 33, no. 4, pp. 538–544, 2013. View at Google Scholar
  65. Y. Liu, Z. Jia, L. Dong, R. Wang, and G. Qiu, “A randomized pilot study of atractylenolide I on gastric cancer cachexia patients,” Evidence-based Complementary and Alternative Medicine, vol. 5, no. 3, pp. 337–344, 2008. View at Publisher · View at Google Scholar · View at Scopus
  66. R. Wong, C. M. Sagar, and S. M. Sagar, “Integration of Chinese medicine into supportive cancer care: a modern role for an ancient tradition,” Cancer Treatment Reviews, vol. 27, no. 4, pp. 235–246, 2001. View at Publisher · View at Google Scholar · View at Scopus
  67. R. Kanawong, T. Obafemi-Ajayi, T. Ma, D. Xu, S. Li, and Y. Duan, “Automated tongue feature extraction for ZHENG classification in traditional Chinese medicine,” Evid Based Complement Alternat Med, vol. 2012, Article ID 912852, 12 pages, 2012. View at Publisher · View at Google Scholar
  68. S. Su, J. Duan, W. Cui et al., “Network-based biomarkers for cold coagulation blood stasis syndrome and the therapeutic effects of Shaofu Zhuyu Decoction in rats,” Evid Based Complement Alternat Med, vol. 2013, Article ID 901943, 15 pages, 2013. View at Publisher · View at Google Scholar